¿Û¿Û´«Ã½

Standout performers from the pandemic face greater uncertainty

After a torrid year for biotech stocks, shrewd investors can pick up bargains. But risks abound

A recent trend is good news for global income funds

Some trusts with high gearing could point to appealing markets

Taking the right administrative steps and tax planning help to maximise the value of an inherited portfolio

January's sell-off proved relatively quiet, by one measure

James Thomson tells Dave Baxter how he is dealing with heightened uncertainty

A reader faces up to a common dilemma

Options and key considerations

Nick Train tells Leonora Walters why he is sticking with quality companies despite recent underperformance